DNA vaccine formulations
US7927870B2 · kind B2 · utility
6Cited by
15References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 10, 2006 |
| Grant date | Apr 19, 2011 |
| Priority date | — |
| Expiry date | Sep 23, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to novel methods and formulations of nucleic acid pharmaceutical products, specifically formulations of nucleic acid vaccine products and nucleic acid gene therapy products. The formulations of the disclosure stabilize the conformation of DNA pharmaceutical products.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.